Friday, June 27, 2014
India's Ranbaxy gains; U.S. drug regulator approves generic version of Novartis drug
A general view of the office of Ranbaxy Laboratories is pictured at Gurgaon, on the outskirts of New Delhi, June 13, 2013.
Credit: Reuters/Adnan Abidi
Source : http://feeds.reuters.com/~r/reuters/healthNews/~3/9conIXjxUqM/story01.htm
